Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer.
APA
Wu J, Wang Y, et al. (2026). Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer.. iScience, 29(3), 114872. https://doi.org/10.1016/j.isci.2026.114872
MLA
Wu J, et al.. "Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer.." iScience, vol. 29, no. 3, 2026, pp. 114872.
PMID
41716846
같은 제1저자의 인용 많은 논문 (5)
- Vitamin B6 preserves the stemness-like phenotypes and antitumor ability of CD8 T cells.
- Advances in light-controllable PROTACs: Design strategies, therapeutic applications and current challenges.
- Efficacy of nerve blocks for postoperative analgesia in lung cancer: A meta-analysis of randomized clinical trials.
- [Clinical characteristics of 20 lung adenocarcinoma patients misdiagnosed as interstitial pneumonia].
- YAP1 signaling and cancer: molecular pathways reveal novel targeting opportunities.